Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BENDITA: Benznidazole Regimens for Chagas Disease
NCT03378661Phase 2Unknown
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of benznidazole, fosravuconazole in Chagas disease, sponsored by Drugs for Neglected Diseases initiative. Status: unknown.
02
Drugs
benznidazolefosravuconazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT03378661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378661.